Get the Stockscreener App
177.32
1.34%
-2.735
Davita Inc stock is traded at $177.32, with a volume of 225.04K.
It is down -1.34% in the last 24 hours and down -25.04% over the past month.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$180.06
Open:
$177.97
24h Volume:
225.04K
Relative Volume:
0.26
Market Cap:
$11.32B
Revenue:
$13.84B
Net Income/Loss:
$1.10B
P/E Ratio:
17.02
EPS:
10.4185
Net Cash Flow:
$1.49B
1W Performance:
-3.29%
1M Performance:
-25.04%
6M Performance:
+18.10%
1Y Performance:
+31.22%
1-Day Range:
$176.42
$180.00
1-Week Range:
$176.42
$186.96
52-Week Range:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
177.40 | 11.49B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
406.63 | 87.61B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
265.45 | 21.57B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.52 | 12.65B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
121.85 | 12.19B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Enterprise value to revenue forward of DaVita Inc. – BX:TRL - TradingView
Bank of America Corp DE Cuts Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DaVita Inc. (DVA) Stock forecasts - Yahoo Finance UK
The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Community Care Report 2025: Creating a Culture of Belonging for All - CSRwire
DaVita Inc. $DVA Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Pacer Advisors Inc. Trims Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc. $DVA Shares Sold by Empowered Funds LLC - MarketBeat
DaVita Inc (DVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Are Wall Street Analysts Bullish on DaVita Stock? - Yahoo Finance
DaVita Inc. $DVA Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
DaVita Inc. (DVA) Stock Analysis: Strong Upside Potential with an 18.86% Gain on the Horizon - directorstalkinterviews.com
9,300 Shares in DaVita Inc. $DVA Purchased by Polianta Ltd - MarketBeat
DaVita (DVA) Stock Still Looks Undervalued Despite A Q2 Earnings Beat - Yahoo Finance
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
Can DaVita’s (DVA) Better Mortality Trends Redefine Its Core Dialysis Investment Story? - webull.com
Why is DaVita stock up 2% today? - Investing.com
DaVita Inc (DVA) Stock News Today - TradingKey
TD Cowen upgrades DaVita stock rating on market position gains - Investing.com
DaVita Shares Rise After TD Cowen Upgrades Stock to Buy - Yahoo Finance
Janus Henderson Group PLC Raises Stock Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc (DVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is DaVita (DVA) a Great Value Stock Right Now? - Yahoo Finance
DaVita Inc. $DVA Shares Bought by California State Teachers Retirement System - MarketBeat
DaVita Inc. (DVA) options chain - Yahoo Finance Australia
SPDR S&P 500(R) Buyback ETF's DaVita Inc(DVA) Holding History - GuruFocus
DaVita Inc (DVA) Shares Fall 17.2% -- GF Value Says Still Overva - GuruFocus
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down - Yahoo Finance
DVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook - stockstory.org
DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth - The Globe and Mail
DaVita Inc. $DVA Shares Sold by Amundi - MarketBeat
DaVita Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
DaVita Inc. Stock 12‑Month Price Target Raised to $230, Implies 1% Upside - TradingView
Is DaVita Inc (DVA) Overvalued After Q2 Earnings Beat? EPS at $4 - GuruFocus
DaVita Expands Access to Advanced Middle Molecule Clearance - DaVita Newsroom
DaVita Q2 Earnings Call Highlights - TradingView
DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volu - GuruFocus
DaVita's Profit Growth Prospects Boosted by Share Repurchases - Morningstar
Earnings call transcript: DaVita beats Q2 2026 estimates but shares fall - Investing.com
DaVita Inc reports results for the quarter ended June 30Earnings Summary - TradingView
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
DaVita Slides as Solid Q2 Results Fail to Lift Full-Year Outlook - Quiver Quantitative
DaVita (NYSE:DVA) Beats Q2 CY2026 Sales Expectations But Stock Drops - StockStory
DaVita Inc. 2026: Revenue $3.55B, EPS $4.02— 10-Q Summary - TradingView
[10-Q] DAVITA INC. Quarterly Earnings Report - Stock Titan
Q2 2026 DaVita Inc Earnings Call Transcript - GuruFocus
Earnings Flash (DVA) DaVita Inc. Posts Q2 Adjusted EPS $4.02 per Share, vs. FactSet Est of $3.88 - marketscreener.com
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):